Bristol-Myers reached a deal with Novo Nordisk for an exclusive license to the Denmark-based drugmaker’s autoimmune disease research program.
from WSJ.com: US Business http://ift.tt/1DTsy4k
via IFTTT
from WSJ.com: US Business http://ift.tt/1DTsy4k
via IFTTT
No comments:
Post a Comment